Borgiani P - Search Results

1

COVID-19 and Genetic Variants of Protein Involved in the SARS-CoV-2 Entry into the Host Cells.

Latini A, Agolini E, Novelli A, Borgiani P, Giannini R, Gravina P, Smarrazzo A, Dauri M, Andreoni M, Rogliani P, Bernardini S, Helmer-Citterich M, Biancolella M, Novelli G. Latini A, et al. Among authors: borgiani p. Genes (Basel). 2020 Aug 27;11(9):1010. doi: 10.3390/genes11091010. Genes (Basel). 2020. PMID: 32867305 Free PMC article.

2

Role of genetics in prevention of coronary atherosclerosis.

Novelli G, Borgiani P, Giardina E, Mango R, Contino G, Romeo F, Mehta JL. Novelli G, et al. Among authors: borgiani p. Curr Opin Cardiol. 2003 Sep;18(5):368-71. doi: 10.1097/00001573-200309000-00008. Curr Opin Cardiol. 2003. PMID: 12960469 Review.

3

Characterization of a single nucleotide polymorphism in the ZNF9 gene and analysis of association with myotonic dystrophy type II (DM2) in the Italian population.

Vallo L, Bonifazi E, Borgiani P, Novelli G, Botta A. Vallo L, et al. Among authors: borgiani p. Mol Cell Probes. 2005 Feb;19(1):71-4. doi: 10.1016/j.mcp.2004.09.003. Epub 2004 Nov 12. Mol Cell Probes. 2005. PMID: 15652222

4

Pharmacogenomics in cardiovascular disease: the role of single nucleotide polymorphisms in improving drug therapy.

Mango R, Vecchione L, Raso B, Borgiani P, Brunetti E, Mehta JL, Lauro R, Romeo F, Novelli G. Mango R, et al. Among authors: borgiani p. Expert Opin Pharmacother. 2005 Dec;6(15):2565-76. doi: 10.1517/14656566.6.15.2565. Expert Opin Pharmacother. 2005. PMID: 16316297 Review.

5

Allelic variants in the CYP2C9 and VKORC1 loci and interindividual variability in the anticoagulant dose effect of warfarin in Italians.

Borgiani P, Ciccacci C, Forte V, Romano S, Federici G, Novelli G. Borgiani P, et al. Pharmacogenomics. 2007 Nov;8(11):1545-50. doi: 10.2217/14622416.8.11.1545. Pharmacogenomics. 2007. PMID: 18034619 Clinical Trial.

6

Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases.

Vecchione L, Gargiul E, Borgiani P, Predazzi I, Mango R, Romeo F, Magnani M, Novelli G. Vecchione L, et al. Among authors: borgiani p. Recent Pat Cardiovasc Drug Discov. 2007 Jun;2(2):147-51. doi: 10.2174/157489007780832506. Recent Pat Cardiovasc Drug Discov. 2007. PMID: 18221114

7

CYP4F2 genetic variant (rs2108622) significantly contributes to warfarin dosing variability in the Italian population.

Borgiani P, Ciccacci C, Forte V, Sirianni E, Novelli L, Bramanti P, Novelli G. Borgiani P, et al. Pharmacogenomics. 2009 Feb;10(2):261-6. doi: 10.2217/14622416.10.2.261. Pharmacogenomics. 2009. PMID: 19207028

8

Pharmacogenomics: role in medicines approval and clinical use.

Novelli G, Borgiani P, Ciccacci C, Di Daniele N, Sirugo G, Papaluca Amati M. Novelli G, et al. Among authors: borgiani p. Public Health Genomics. 2010;13(5):284-91. doi: 10.1159/000245271. Epub 2009 Oct 6. Public Health Genomics. 2010. PMID: 19815999 Review.

9

Nevirapine-induced hepatotoxicity and pharmacogenetics: a retrospective study in a population from Mozambique.

Ciccacci C, Borgiani P, Ceffa S, Sirianni E, Marazzi MC, Altan AM, Paturzo G, Bramanti P, Novelli G, Palombi L. Ciccacci C, et al. Among authors: borgiani p. Pharmacogenomics. 2010 Jan;11(1):23-31. doi: 10.2217/pgs.09.142. Pharmacogenomics. 2010. PMID: 20017669

10

Characterization of a novel CYP2C9 gene mutation and structural bioinformatic protein analysis in a warfarin hypersensitive patient.

Ciccacci C, Falconi M, Paolillo N, Oteri F, Forte V, Novelli G, Desideri A, Borgiani P. Ciccacci C, et al. Among authors: borgiani p. Pharmacogenet Genomics. 2011 Jun;21(6):344-6. doi: 10.1097/FPC.0b013e328344c340. Pharmacogenet Genomics. 2011. PMID: 21451434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

147 results

Search Page

Filters